Overview

Pharmacokinetics, Pharmacodynamics, and Safety of Alogliptin in Children, Adolescents and Adults With Type 2 Diabetes Mellitus

Status:
Completed

Trial end date:
2013-11-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to determine the pharmacokinetic and safety profile of alogliptin in children, adolescents, and adults with type 2 diabetes mellitus.

Phase:

Phase 1

Details

Lead Sponsor:

Takeda

Treatments:

Alogliptin